search for



Cross mark




View (44) Download (26) CrossRef (1)
Problems and Alternatives for Korea National Lung Cancer Screening Program for Smoking Cessation: Analysis of a Survey Involving Experts
J Korean Soc Res Nicotine Tob 2024; 15(2): 49-56
Published online June 30, 2024
© 2024 The Korean Society for Research on Nicotine and Tobacco.

Cheol Min Lee1,2*, Sil Vi Han Park3, Jinri Kim4, Bumjo Oh2,5, Kiheon Lee2,6, Yeol Kim7, Yu-Jin Paek8

1Department of Family Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, 2Department of Family Medicine, Seoul National University College of Medicine, Seoul, 3Department of Family Medicine, Daerim St. Mary’s Hospital, Seoul, 4Department of Family Medicine, H+ Yangji Hospital, Seoul, 5Department of Family Medicine, Seoul National University Boramae Medical Center, Seoul, 6Department of Family Medicine, Seoul National University Bundang Hospital, Seongnam, 7National Cancer Control Institute, National Cancer Center, Goyang, 8Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea
Correspondence to: *이철민
서울대학교병원 강남센터
Received May 14, 2024; Revised June 24, 2024; Accepted June 24, 2024.
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.
Background: Since 2019, the National Lung Cancer Screening Program, which targets high-risk smokers, has made smoking cessation counseling mandatory during result consultations in Korea. To implement smoking cessation counseling, we surveyed experts to investigate the status, issues, and improvement measures of smoking cessation counseling.
Methods: We designed a survey to assess the status of smoking cessation counseling (including whether it is conducted during lung cancer screening result consultations, methods used, frequency of prescribing smoking cessation medications, among others) and improvement measures (from the perspectives of examinees, counseling physicians, clinic managers, and government officials). In December 2023, we sought cooperation from the top 100 institutions with high screening implementation rates and received responses from 35 individuals, including counseling physicians and smoking cessation specialists. We allowed for multiple responses and described the frequency for each survey separately.
Results: Of smokers, 71.4% received smoking cessation counseling, primarily within 3 minutes on the result consultation day (61.1%). Only 36.1% of smokers were registered for same-day support programs and medication prescriptions. Only 13.9% of smokers were frequently prescribed cessation medications, with 30.6% having never been prescribed cessation medication. Improvement suggestions included showing lung cancer screening results (55.6% by examinees), reimbursement for medications (58.3% by physicians and government), and increasing counseling sessions (63.9% by clinic management).
Conclusion: Even among proactive experts in lung cancer screening and smoking cessation counseling, frequency of actual prescription of cessation medications was low. Experts suggested alternatives such as increasing reimbursement, coverage for smoking cessation medications and treatment, and separate pricing for counseling.
Keywords : Lung cancer screening; Smoking cessation; Expert; Survey
  1. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004; 328(7455): 1519.
    Pubmed KoreaMed CrossRef
  2. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Reports of the Surgeon General. Atlanta (GA)2014.
  3. Kang MJ, Jung KW, Bang SH, Choi SH, Park EH, Yun EH, et al. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020. Cancer Res Treat. 2023; 55(2): 385-99.
    Pubmed KoreaMed CrossRef
  4. Phs Guideline Update Panel L, Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008; 53(9): 1217-22.
  5. National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5): 395-409.
    Pubmed KoreaMed CrossRef
  6. Tanner NT, Kanodra NM, Gebregziabher M, Payne E, Halbert CH, Warren GW, et al. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016; 193(5): 534-41.
    Pubmed CrossRef
  7. Park J, Lee J, Kim Y. Public opinion on implementing the National Lung Cancer Screening Program in Korea. Transl Lung Cancer Res. 2021; 10(3): 1355-67.
    Pubmed KoreaMed CrossRef
  8. Kim W, Lee SC, Lee WR, Chun S. The effect of the introduction of the national lung cancer screening program on short-term mortality in Korea. Lung Cancer. 2023; 186: 107412.
    Pubmed CrossRef
  9. Steliga MA, Yang P. Integration of smoking cessation and lung cancer screening. Transl Lung Cancer Res. 2019; 8(Suppl 1): S88-S94.
    Pubmed KoreaMed CrossRef
  10. Kim Y, Lee J, Lee E, Lim J, Kim Y, Lee CT, et al. Strategies to Improve Smoking Cessation for Participants in Lung Cancer Screening Program: Analysis of Factors Associated with Smoking Cessation in Korean Lung Cancer Screening Project (K-LUCAS). Cancer Res Treat. 2024; 56(1): 92-103.
    Pubmed KoreaMed CrossRef
  11. Williams PJ, Philip KE, Alghamdi SM, Perkins AM, Buttery SC, Polkey MI, et al. Strategies to deliver smoking cessation interventions during targeted lung health screening - a systematic review and meta-analysis. Chron Respir Dis. 2023; 20: 14799731231183446.
    Pubmed KoreaMed CrossRef
  12. Williams RM, Eyestone E, Smith L, Philips JG, Whealan J, Webster M, et al. Engaging Patients in Smoking Cessation Treatment within the Lung Cancer Screening Setting: Lessons Learned from an NCI SCALE Trial. Curr Oncol. 2022; 29(4): 2211-24.
    Pubmed KoreaMed CrossRef
  13. Fillon M. Pairing smoking cessation with lung cancer screening may save lives. CA Cancer J Clin. 2021; 71(4): 283-4.
    Pubmed CrossRef
  14. Steliga MA. Smoking Cessation in Clinical Practice: How to Get Patients to Stop. Semin Thorac Cardiovasc Surg. 2018; 30(1): 87-91.
    Pubmed CrossRef
  15. Moldovanu D, de Koning HJ, van der Aalst CM. Lung cancer screening and smoking cessation efforts. Transl Lung Cancer Res. 2021; 10(2): 1099-109.
    Pubmed KoreaMed CrossRef
  16. Evans WK, Tammemagi MC, Walker MJ, Cameron E, Leung YW, Ashton S, et al. Integrating Smoking Cessation Into Low-Dose Computed Tomography Lung Cancer Screening: Results of the Ontario, Canada Pilot. J Thorac Oncol. 2023; 18(10): 1323-33.
    Pubmed CrossRef
  17. Richter KP, Catley D, Gajewski BJ, Faseru B, Shireman TI, Zhang C, et al. The Effects of Opt-out vs Opt-in Tobacco Treatment on Engagement, Cessation, and Costs: A Randomized Clinical Trial. JAMA Intern Med. 2023; 183(4): 331-9.
    Pubmed KoreaMed CrossRef
  18. Taylor KL, Cox LS, Zincke N, Mehta L, McGuire C, Gelmann E. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer. 2007; 56(1): 125-34.
    Pubmed CrossRef
  19. Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control. 2007; 16 Suppl 1(Suppl 1): i53-9.
    Pubmed KoreaMed CrossRef
  20. Cao P, Jeon J, Levy DT, Jayasekera JC, Cadham CJ, Mandelblatt JS, et al. Potential Impact of Cessation Interventions at the Point of Lung Cancer Screening on Lung Cancer and Overall Mortality in the United States. J Thorac Oncol. 2020; 15(7): 1160-9.
    Pubmed KoreaMed CrossRef
  21. Murray RL, Alexandris P, Baldwin D, Brain K, Britton J, Crosbie PAJ, et al. Uptake and 4-week quit rates from an opt-out co-located smoking cessation service delivered alongside community-based low-dose computed tomography screening within the Yorkshire Lung Screening Trial. Eur Respir J. 2024; 63(4).
    Pubmed KoreaMed CrossRef